Tom Moore

I am a transformational C-level financial executive with extensive experience in serving both Fortune 50 (Multinational) and start-up companies in all elements of the healthcare and pharmaceutical industries. A dynamic change agent who offers demonstrated abilities to quickly turning around operations and integrating acquisitions to improve productivity and profitability.  Leverages a rare combination of business acumen and financial savvy to efficiently analyze operating processes, identify key financial drivers, and design systems to optimize performance.  Partnered successfully with senior leadership to define the corporate vision, develop and implement strategic plans.

I have spent the last 12 years of my working as a CFO for portfolio companies within the framework of private equity-backed companies.  This includes working 7 years as a CFO for SMS, which is a portfolio company within the Riverside Microcap fund.  I have also worked on due diligence assignments on both the buy and sell side.

In addition, I have worked in senior financial and operational/logistics positions for Cardinal Health, McKesson Drug Company, Apotex Corp and MAX IT Healthcare, and most recently, Specialized Medical Services.

Data Points

• Bachelor of Business Administration, majoring in accounting-American International College
• Master of Business Administration – Western New England University
• ERP System Expertise-SAP, GD Edwards, Quick Books, and Mas 200 Sage software
• Home base:  Venice Florida

Industries:  Healthcare (All elements of the supply chain) manufacturing, distribution, and service industries.

• Partnered with a new CEO to both turns around the performance and sell the company.  Facilitated multiple due diligence processes resulting in the successful sale of two (2) separate business units of the company.
• Performed post-acquisition due diligence, resulting in a savings/recovery of $217k as it relates to changing the working capital peg balance.  This action resulted in a legal recovery action against the seller.
• Managed all aspects of a medical company acquisition.  Executed corporate synergies across administration and operations resulting in a savings of $325,000.  Successfully integrated systems and business processes.
• Implemented and managed a start-up pharmaceutical warehouse, which resulted in savings of $550,000 as compared to the previous out-sourced distribution model.
• Directed internal audit of the financial statements, resulting in material positive adjustments to the P&L in the amount of $700,000.
• Reduced debt by $850,000, increased working capital and decreased DSO by four days by implementing accounts receivable management disciplines.
• Implemented a contract/chargeback process projected to produce annual savings of more than $1 million.
• Advanced customer and product profitability models that expanded bottom-line profit by $1.2 million.
• Enlisted by Mexichem to perform a financial valuation of an $80M capital investment project involving entry into the US Pharmaceutical Market.
• Introduced an inventory reduction program that trimmed the inventory investment by $150 million.
• Designed and executed critical working capital initiatives and spearheaded tactical plan that improved EBITA by 44%.
• Propelled an 89% increase in profit over the previous fiscal year through effective management of profit improvement plans, including multiple inventories, expense, and customer service initiatives.

Implemented critical working capital initiatives to improve cash flow.  Reduces DSO by 10 days and increased DPO by 20 days. This was accomplished without any interruption of Service level.